This analysis shows the potential of the presented methodology to not only identify potential biomarkers but also deregulated processes with a notable trend providing data-driven hypotheses that have either already been validated or that better yet have not been associated with the disease and need further validation. 2 Materials and Methods The cornerstone of this methodology is for each group of interest to be compared to their most appropriate controls.
← all excerpts
Integrative OMICS Data-Driven Procedure Using a Derivatized Meta-Analysis Approach.
1
—
—